JMADX
Price
$8.50
Change
-$0.02 (-0.23%)
Updated
Nov 13 closing price
Net Assets
166.98M
VWEAX
Price
$5.53
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Net Assets
25.64B
Interact to see
Advertisement

JMADX vs VWEAX

Header iconJMADX vs VWEAX Comparison
Open Charts JMADX vs VWEAXBanner chart's image
JHancock Mgd Acct Shrs Non-IG CorpBdPort
Price$8.50
Change-$0.02 (-0.23%)
VolumeN/A
Net Assets166.98M
Vanguard High-Yield Corporate Adm
Price$5.53
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets25.64B
JMADX vs VWEAX Comparison Chart in %
View a ticker or compare two or three
VS
JMADX vs. VWEAX commentary
Nov 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMADX is a Hold and VWEAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VWEAX has more cash in the bank: 25.6B vs. JMADX (167M). JMADX pays higher dividends than VWEAX: JMADX (7.17) vs VWEAX (6.25). JMADX was incepted earlier than VWEAX: JMADX (6 years) vs VWEAX (24 years). JMADX (0.78) is less costly to investors than VWEAX (0.12). JMADX is a more actively managed with annual turnover of: 43.00 vs. VWEAX (37.00). JMADX has a lower initial minimum investment than VWEAX: JMADX (0) vs VWEAX (50000). JMADX annual gain was more profitable for investors over the last year : 6.87 vs. VWEAX (1.82). JMADX return over 5 years is better than : 21.97 vs. VWEAX (-5.17).
JMADXVWEAXJMADX / VWEAX
Total Expense Ratio0.000.12-
Annual Report Gross Expense Ratio0.780.12650%
Fund Existence6 years24 years-
Gain YTD6.3712.574247%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets167M25.6B1%
Annual Yield % from dividends7.176.25115%
Returns for 1 year6.871.82377%
Returns for 3 years30.468.46360%
Returns for 5 years21.97-5.17-425%
Returns for 10 yearsN/A17.02-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX21.770.01
+0.05%
Saratoga Health & Biotechnology A
OCSVX10.63-0.14
-1.30%
Optimum Small-Mid Cap Value C
TRLHX25.10-0.34
-1.34%
Nuveen Large Cap Value I
ETLCX15.10-0.26
-1.69%
Eventide Large Cap Focus C
IOAPX31.59-0.55
-1.71%
Invesco Main Street All Cap R6